Mumbai, Sept. 26 -- The frontline benchmarks traded with modest losses in the mid-morning trade after the U.S President Donald Trump announced a 100% tariff on branded drug imports starting from 1 Oct 2025, pressuring pharma stocks despite generics being exempt. The Nifty slipped below the 24,800 mark, while IT stocks extended losses for the sixth consecutive trading session.

At 11:27 IST, the barometer index, the S&P BSE Sensex, slipped 392.72 points or 0.48% to 80,783.34. The Nifty 50 index lost 123.05 points or 0.49% to 24,767.85.

The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index fell 1.05% and the S&P BSE Small-Cap index tumbled 1.33%.

The market breadth was weak. On the BSE, 1,091 shares rose and 2,7...